Febrile ConvulsionNCT07027501
The Evaluation of the Effectiveness of Febrile Seizure Training Given to Parents
A study testing The video based education group in people with Febrile Convulsion, run by Zonguldak Bulent Ecevit University at 1 site in Turkey (Türkiye).
Trial summary
Objective: The aim of this study was to evaluate the effectiveness of a video-based educational intervention delivered via QR code to parents of hospitalized children aged 6 months to 5 years-an age group in which febrile seizures are most commonly observed. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Febrile Convulsion
- What is being tested?
- The video based education group
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 76 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 29 Nov 2024to 20 Jun 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- The child has been hospitalized. The child is between 6 months and 5 years old. The parent can speak and understand Turkish. The parent agrees to participate in the study.
Who cannot join
- The child has not been hospitalized. The child is younger than 6 months. The child is older than 5 years. The parent or legal guardian cannot speak or understand Turkish. The parent does not agree to participate in the study.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Evaluation of the Effectiveness of Febrile Seizure Training Given to Parents of Children Aged 6 Months to 5 Years
Objective: The aim of this study was to evaluate the effectiveness of a video-based educational intervention delivered via QR code to parents of hospitalized children aged 6 months to 5 years-an age group in which febrile seizures are most commonly observed.
Read the detailed description
Method: This study will be designed as a randomized controlled trial. The study population will consist of parents of children aged between 6 months and 5 years who are hospitalized in the pediatric wards of Kdz. Eregli State Hospital during the data collection period (September 1, 2024 - September 1, 2025). The sample will include 100 parents-50 in the intervention group and 50 in the control group-who meet the inclusion criteria.
Eligibility criteria for sampling; The child must have been hospitalized. The child must be between 6 months and 5 years of age. The parent must be able to speak and understand Turkish. The parent must agree to participate in the study Data collection: Between September 1, 2024, and September 1, 2025, the "Child and Parent Introductory Information Form" and the "Febrile Convulsion Knowledge Level Scale for Parents/Caregivers" will be completed by participants who meet the eligibility criteria.
No educational session or brochure will be provided to the control group. In the intervention group, after completing the "Child and Parent Introductory Information Form " and the "Febrile Convulsion Knowledge Level Scale for Parents/Caregivers", participants will be shown the educational brochure and granted access to the video training via the QR code included in the brochure.
At the end of the training, the "Febrile Convulsion Knowledge Level Scale for Parents/Caregivers" will be administered again. The brochure used in the training will be distributed to all participants in the intervention group.
Four weeks after the training, participants in the intervention group will be contacted again, and their data will be recollected using the same scale to assess knowledge retention and the long-term effectiveness of the training. Similarly, in the control group, the "Febrile Convulsion Knowledge Level Scale for Parents/Caregivers "will be re-administered four weeks after the initial data collection.
Data Analysis:
The data will be analyzed using the SPSS version 27.0 software.
- Conditions
- Febrile Convulsion
- Being tested
- The video based education group
- Keywords
- febrile convulsion, fever, education, QR
- Medical subject headings
- Seizures, Febrile, Fever
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
The video based education groupOther
The parents in the intervention group were provided with a video-based educational material on febrile seizures, which they accessed via a QR code.
| Study group | Role | What they receive |
|---|---|---|
| control | Other | No video-based educational intervention was administered to the control group Receives: Other: The video based education group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Outcome Measure Title: Change in Knowledge Levels Regarding Febrile Seizures Among Parents, Measured by the Febrile Seizure Knowledge Assessment Questionnaire
Measured: Knowledge scores were measured at baseline, immediately after training (1 hour later), and 4 weeks later in both intervention and control groups.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Jun 2025
- Study start29 Nov 2024
- Primary completion7 Jan 2025
- Study completion20 Jun 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Febrile ConvulsionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- The study included two groups: an intervention group and a control group.
- Masking
- None (open label)
- Enrolment
- 76 participants (actual)
Sponsor and investigators
- Lead sponsor
- Zonguldak Bulent Ecevit University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, TUĞÇE ŞİRİN, Zonguldak Bulent Ecevit University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07027501
- Sponsor's protocol ID
- ZBEU-TUGCE SIRIN-001
- Other IDs
- ZBEU
- Status last verified
- Jun 2025
- First submitted
- 21 May 2025
- Last updated
- 18 Jun 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The data collected include sensitive personal and health information, and participants were not explicitly informed or consented to data sharing beyond the scope of this study. Therefore, to protect participant confidentiality and comply with ethical guidelines, the IPD will not be shared with other researchers.
Study at a glance
From the registry record, last updated by the sponsor on 18 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Evaluation of the Effectiveness of Febrile Seizure Training Given to Parents of Children Aged 6 Months to 5 Years
- ClinicalTrials.gov ID
- NCT07027501
- Acronym / sponsor ID
- ZBEU-TUGCE SIRIN-001
- Conditions
- Febrile Convulsion
- Keywords
- febrile convulsion, fever, education, QR
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 76 participants (actual)
- Lead sponsor
- Zonguldak Bulent Ecevit UniversityUniversity, hospital or other
- Study start
- 29 Nov 2024 (actual)
- Primary completion
- 7 Jan 2025 (actual)
- Study completion
- 20 Jun 2025 (estimated)
- First posted
- 18 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Objective: The aim of this study was to evaluate the effectiveness of a video-based educational intervention delivered via QR code to parents of hospitalized children aged 6 months to 5 years-an age group in which febrile seizures are most commonly observed.
Detailed description
Method: This study will be designed as a randomized controlled trial. The study population will consist of parents of children aged between 6 months and 5 years who are hospitalized in the pediatric wards of Kdz. Eregli State Hospital during the data collection period (September 1, 2024 - September 1, 2025). The sample will include 100 parents-50 in the intervention group and 50 in the control group-who meet the inclusion criteria.
Eligibility criteria for sampling; The child must have been hospitalized. The child must be between 6 months and 5 years of age. The parent must be able to speak and understand Turkish. The parent must agree to participate in the study Data collection: Between September 1, 2024, and September 1, 2025, the "Child and Parent Introductory Information Form" and the "Febrile Convulsion Knowledge Level Scale for Parents/Caregivers" will be completed by participants who meet the eligibility criteria.
No educational session or brochure will be provided to the control group. In the intervention group, after completing the "Child and Parent Introductory Information Form " and the "Febrile Convulsion Knowledge Level Scale for Parents/Caregivers", participants will be shown the educational brochure and granted access to the video training via the QR code included in the brochure.
At the end of the training, the "Febrile Convulsion Knowledge Level Scale for Parents/Caregivers" will be administered again. The brochure used in the training will be distributed to all participants in the intervention group.
Four weeks after the training, participants in the intervention group will be contacted again, and their data will be recollected using the same scale to assess knowledge retention and the long-term effectiveness of the training. Similarly, in the control group, the "Febrile Convulsion Knowledge Level Scale for Parents/Caregivers "will be re-administered four weeks after the initial data collection.
Data Analysis:
The data will be analyzed using the SPSS version 27.0 software.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- The study included two groups: an intervention group and a control group.
| Arm | Type | Receives |
|---|---|---|
| control | Other | Other: The video based education groupNo video-based educational intervention was administered to the control group |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- The child has been hospitalized. The child is between 6 months and 5 years old. The parent can speak and understand Turkish. The parent agrees to participate in the study.
Key exclusion criteria (1 listed)
- The child has not been hospitalized. The child is younger than 6 months. The child is older than 5 years. The parent or legal guardian cannot speak or understand Turkish. The parent does not agree to participate in the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| The video based education groupThe parents in the intervention group were provided with a video-based educational material on febrile seizures, which they accessed via a QR code. | Other | control |
Primary outcome
Outcome Measure Title: Change in Knowledge Levels Regarding Febrile Seizures Among Parents, Measured by the Febrile Seizure Knowledge Assessment Questionnaire
Time frame: Knowledge scores were measured at baseline, immediately after training (1 hour later), and 4 weeks later in both intervention and control groups.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Jun 2025.
- Individual participant dataSharing planned: No. The data collected include sensitive personal and health information, and participants were not explicitly informed or consented to data sharing beyond the scope of this study. Therefore, to protect participant confidentiality and comply with ethical guidelines, the IPD will not be shared with other researchers.
Related trials for Febrile Convulsion
Active, not recruitingPhase 1
A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia
Familial Erythromelalgia
RecruitingPhase 1/2
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
Dravet Syndrome
Not yet recruitingPhase 3
COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"
New Onset Refractory Status Epilepticus, New-Onset Refractory Status Epilepticus
RecruitingEarly Phase 1
A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome
Dravet Syndrome (DS)
Not yet recruiting
Efficacy and Safety of Daily Home-based Hyperthermic Baths for Reducing Epileptic Seizures in CDKL5 Deficiency Disorder: A PROBE Clinical Trial
CDKL5 Deficiency Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing The video based education group in people with Febrile Convulsion, run by Zonguldak Bulent Ecevit University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 18 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Outcome Measure Title: Change in Knowledge Levels Regarding Febrile Seizures Among Parents, Measured by the Febrile Seizure Knowledge Assessment Questionnaire (time frame: Knowledge scores were measured at baseline, immediately after training (1 hour later), and 4 weeks later in both intervention and control groups.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2025.